Pharma-Bio Serv (PBSV) Cash from Discontinued Operations (2018)

Pharma-Bio Serv (PBSV) posted Cash from Discontinued Operations of 325159.0 for Q4 2018, down 41.85% on a QoQ basis from 559219.0 in Q3 2018.

Pharma-Bio Serv (PBSV) Cash from Discontinued Operations (2018) Analysis & Trends

Pharma-Bio Serv's Cash from Discontinued Operations history runs 1 years deep, the most recent figure standing at 325159.0 for Q4 2018.

Quarterly Cash from Discontinued Operations changed N/A year-over-year to 325159.0 in Q4 2018, while the trailing twelve-month figure through Jul 2019 was 325159.0 (changed N/A YoY) and the FY2018 annual result came in at 728726.0, up 192.75% from the prior year.
Cash from Discontinued Operations was 325159.0 for Q4 2018 at Pharma-Bio Serv, down from 559219.0 in the prior quarter.
Across five years, Cash from Discontinued Operations topped out at 559219.0 in Q3 2018 and bottomed at 277995.0 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Discontinued Operations (Qtr)
1	Veeva Systems	32.00 Bn	24.69 Bn	662.02 Mn	-
2	BrightSpring Health Services	14.72 Bn	13.82 Bn	482.22 Mn	-
3	Healthequity	8.29 Bn	8.02 Bn	256.31 Mn	-
4	Hinge Health	5.99 Bn	5.67 Bn	154.23 Mn	-
5	10x Genomics	5.92 Bn	5.38 Bn	106.18 Mn	-
6	MiniMed	4.51 Bn	4.22 Bn	480.00 Mn	-
7	Waystar Holding	4.47 Bn	4.41 Bn	216.84 Mn	-
8	Doximity	3.95 Bn	3.20 Bn	125.97 Mn	-
9	Privia Health	3.15 Bn	2.73 Bn	-	-
10	Pharma-Bio Serv	13.28 Mn	4.81 Mn	902,041.00	-

Download Data